{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-145678","form_type":"8-K","ticker":"ENOV","cik":"0001420800","company_name":"Enovis CORP","filed_at":"2022-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.620755+00:00","generated_at":"2026-06-25T21:34:51.641430+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Enovis reports Q1 adjusted stand-alone sales up 21% to $375M, EBITDA up 25%","bullets":["Sales of $375M (+21% total, +7% organic); Recon +72% (+12% organic), P&R +4% (+6% organic).","Adjusted stand-alone EBITDA of $48M (margin 12.7%, +40bps YoY); adjusted EPS $0.37.","Reaffirmed FY2022 guidance: revenue growth 10-14%, EBITDA $245-265M, EPS $2.20-2.40.","Completed spin-off of ESAB on April 4; strong balance sheet with near zero net leverage."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-145678","json":"https://secwatch.observer/filing/0001193125-22-145678.json","markdown":"https://secwatch.observer/filing/0001193125-22-145678.md","text":"https://secwatch.observer/filing/0001193125-22-145678.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420800/000119312522145678/0001193125-22-145678-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420800/000119312522145678/d358965d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:34:51.641430+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}